| Literature DB >> 23915248 |
Mark J Margres1, Karalyn Aronow, Jacob Loyacano, Darin R Rokyta.
Abstract
BACKGROUND: Snake venom is shaped by the ecology and evolution of venomous species, and signals of positive selection in toxins have been consistently documented, reflecting the role of venoms as an ecologically critical phenotype. New World coral snakes (Elapidae) are represented by three genera and over 120 species and subspecies that are capable of causing significant human morbidity and mortality, yet coral-snake venom composition is poorly understood in comparison to that of Old World elapids. High-throughput sequencing is capable of identifying thousands of loci, while providing characterizations of expression patterns and the molecular evolutionary forces acting within the venom gland.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23915248 PMCID: PMC3750283 DOI: 10.1186/1471-2164-14-531
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1The venom-gland transcriptome of was extremely biased towards toxin production. The venom-gland transcriptome of M. fulvius was dominated by toxin transcripts and, in particular, phospholipases A2 (PLA2s). (A) A total of 1,950 nontoxin-encoding and 116 toxin-encoding transcripts were identified. Toxins were grouped into 75 clusters based on <1% nucleotide divergence. The inset shows a magnification of the top 200 transcripts, the vast majority of which code for toxins. (B) Expression levels of individual toxin clusters, color coded by toxin class. The 75 toxin clusters represent 15 distinct toxin classes. Three-finger toxin and PLA2 transcripts dominated toxin expression levels, accounting for nearly 86% of all toxin reads. Toxin-class abbreviations are as follows: 3FTx: three-finger toxin; CTL: C-type lectin; CREGF: cysteine-rich with EGF-like domain; HYAL: hyaluronidase; KUN: Kunitz-type protease inhibitor; LAAO: L amino-acid oxidase; LCN: long-chain neurotoxin; NGF: nerve growth factor; NP: natriuretic peptide; NUC: nucleotidase; PDE: phosphodiesterase; PLA2: phospholipase A2; PLB: phospholipase B; SVMP: snake venom metalloproteinase; VEGF: vascular endothelial growth factor.
Expression levels of toxin clusters
| 1 | PLA2-2 | 11 | 643 | 5.366 | 2.455 | a: GAEP01002032 |
| | | | | | | b: GAEP01002033 |
| | | | | | | c: GAEP01002034 |
| | | | | | | d: GAEP01002035 |
| | | | | | | e: GAEP01002036 |
| | | | | | | f: GAEP01002037 |
| | | | | | | g: GAEP01002038 |
| | | | | | | h: GAEP01002039 |
| | | | | | | i: GAEP01002040 |
| | | | | | | j: GAEP01002041 |
| | | | | | | k: GAEP01002042 |
| 2 | PLA2-5 | 2 | 826 | 5.294 | 2.422 | a: GAEP01002053 |
| | | | | | | b: GAEP01002054 |
| 3 | PLA2-16 | 1 | 815 | 5.036 | 2.304 | GAEP01002014 |
| 4 | 3FTx-2 | 6 | 616 | 4.803 | 2.197 | a: GAEP01001961 |
| | | | | | | b: GAEP01001962 |
| | | | | | | c: GAEP01001963 |
| | | | | | | d: GAEP01001964 |
| | | | | | | e: GAEP01001965 |
| | | | | | | f: GAEP01001966 |
| 5 | PLA2-1 | 4 | 809 | 4.195 | 1.919 | a: GAEP01002018 |
| | | | | | | b: GAEP01002019 |
| | | | | | | c: GAEP01002020 |
| | | | | | | d: GAEP01002021 |
| 6 | PLA2-17 | 1 | 681 | 3.541 | 1.620 | GAEP01002015 |
| 7 | 3FTx-1 | 4 | 394 | 3.424 | 1.567 | a: GAEP01001957 |
| | | | | | | b: GAEP01001958 |
| | | | | | | c: GAEP01001959 |
| | | | | | | d: GAEP01001960 |
| 8 | 3FTx-3 | 2 | 532 | 3.327 | 1.522 | a: GAEP01001967 |
| | | | | | | b: GAEP01001968 |
| 9 | PLA2-11 | 1 | 1,534 | 3.162 | 1.447 | GAEP01002009 |
| 10 | PLA2-12 | 1 | 776 | 3.031 | 1.387 | GAEP01002010 |
| 11 | SVMP-1 | 1 | 2,323 | 2.947 | 1.348 | GAEP01002063 |
| 12 | PLA2-4 | 6 | 702 | 2.924 | 1.338 | a: GAEP01002047 |
| | | | | | | b: GAEP01002048 |
| | | | | | | c: GAEP01002049 |
| | | | | | | d: GAEP01002050 |
| | | | | | | e: GAEP01002051 |
| | | | | | | f: GAEP01002052 |
| 13 | PLA2-26 | 1 | 638 | 2.856 | 1.307 | GAEP01002028 |
| 14 | PLA2-24 | 1 | 760 | 2.835 | 1.297 | GAEP01002026 |
| 15 | PLA2-14 | 1 | 1,074 | 2.801 | 1.281 | GAEP01002012 |
| 16 | 3FTx-4 | 2 | 568 | 2.617 | 1.197 | a: GAEP01001969 |
| | | | | | | b: GAEP01001970 |
| 17 | PLA2-3 | 2 | 874 | 2.278 | 1.042 | a: GAEP01002045 |
| | | | | | | b: GAEP01002046 |
| 18 | PLA2-8 | 1 | 1,846 | 2.001 | 0.915 | GAEP01002060 |
| 19 | PLA2-29 | 1 | 487 | 1.913 | 0.875 | GAEP01002031 |
| 20 | 3FTx-6 | 1 | 382 | 1.873 | 0.857 | GAEP01001973 |
| 21 | PLA2-6 | 3 | 681 | 1.860 | 0.851 | a: GAEP01002055 |
| | | | | | | b: GAEP01002056 |
| | | | | | | c: GAEP01002057 |
| 22 | PLA2-20 | 1 | 825 | 1.518 | 0.695 | GAEP01002022 |
| 23 | PLA2-23 | 1 | 876 | 1.425 | 0.652 | GAEP01002025 |
| 24 | PLA2-7 | 2 | 782 | 1.411 | 0.645 | a: GAEP01002058 |
| | | | | | | b: GAEP01002059 |
| 25 | PLA2-27 | 1 | 550 | 1.361 | 0.623 | GAEP01002029 |
| 26 | PLA2-28 | 1 | 565 | 1.333 | 0.610 | GAEP01002030 |
| 27 | PLA2-13 | 1 | 754 | 1.302 | 0.596 | GAEP01002011 |
| 28 | PLA2-30 | 1 | 730 | 1.182 | 0.541 | GAEP01002043 |
| 29 | 3FTx-7 | 1 | 603 | 1.145 | 0.524 | GAEP01001974 |
| 30 | PLA2-9 | 1 | 631 | 1.097 | 0.502 | GAEP01002061 |
| 31 | PLA2-22 | 1 | 666 | 1.006 | 0.460 | GAEP01002024 |
| 32 | 3FTx-9 | 1 | 593 | 0.992 | 0.454 | GAEP01001976 |
| 33 | LCN-4 | 1 | 471 | 0.985 | 0.451 | GAEP01001999 |
| 34 | PLA2-25 | 1 | 515 | 0.897 | 0.410 | GAEP01002027 |
| 35 | LAAO-1 | 3 | 2,359 | 0.880 | 0.403 | a: GAEP01001991 |
| | | | | | | b: GAEP01001992 |
| | | | | | | c: GAEP01001993 |
| 36 | PLA2-19 | 1 | 985 | 0.798 | 0.365 | GAEP01002017 |
| 37 | LCN-1 | 3 | 613 | 0.795 | 0.364 | a: GAEP01001994 |
| | | | | | | b: GAEP01001995 |
| | | | | | | c: GAEP01001996 |
| 38 | CTL-1 | 2 | 939 | 0.790 | 0.361 | a: GAEP01001978 |
| | | | | | | b: GAEP01001979 |
| 39 | 3FTx-11 | 1 | 496 | 0.784 | 0.359 | GAEP01001952 |
| 40 | KUN-2 | 1 | 551 | 0.782 | 0.358 | GAEP01001984 |
| 41 | PLA2-15 | 1 | 620 | 0.754 | 0.345 | GAEP01002013 |
| 42 | PLA2-31 | 1 | 506 | 0.720 | 0.330 | GAEP01002044 |
| 43 | NP-1 | 1 | 642 | 0.701 | 0.321 | GAEP01002005 |
| 44 | LCN-3 | 1 | 591 | 0.673 | 0.309 | GAEP01001998 |
| 45 | VEGF-1 | 1 | 4,642 | 0.629 | 0.288 | GAEP01002064 |
| 46 | KUN-1 | 2 | 421 | 0.600 | 0.274 | a: GAEP01001982 |
| | | | | | | b: GAEP01001983 |
| 47 | NGF-1 | 2 | 1,014 | 0.576 | 0.264 | a: GAEP01002003 |
| | | | | | | b: GAEP01002004 |
| 48 | PLA2-18 | 1 | 651 | 0.576 | 0.263 | GAEP01002016 |
| 49 | 3FTx-14 | 1 | 377 | 0.522 | 0.239 | GAEP01001955 |
| 50 | LCN-6 | 1 | 548 | 0.504 | 0.231 | GAEP01002001 |
| 51 | 3FTx-12 | 1 | 605 | 0.448 | 0.205 | GAEP01001953 |
| 52 | 3FTx-13 | 1 | 492 | 0.439 | 0.201 | GAEP01001954 |
| 53 | LCN-2 | 1 | 734 | 0.390 | 0.179 | GAEP01001997 |
| 54 | 3FTx-10 | 1 | 417 | 0.371 | 0.170 | GAEP01001951 |
| 55 | LCN-5 | 1 | 487 | 0.345 | 0.158 | GAEP01002000 |
| 56 | LCN-7 | 1 | 371 | 0.339 | 0.155 | GAEP01002002 |
| 57 | PLB-1 | 1 | 1,790 | 0.337 | 0.154 | GAEP01002062 |
| 58 | PLA2-21 | 1 | 668 | 0.325 | 0.149 | GAEP01002023 |
| 59 | KUN-7 | 1 | 442 | 0.303 | 0.139 | GAEP01001989 |
| 60 | KUN-3 | 1 | 442 | 0.284 | 0.130 | GAEP01001985 |
| 61 | VEGF-2 | 1 | 1,260 | 0.248 | 0.113 | GAEP01002065 |
| 62 | NUC-1 | 1 | 2,297 | 0.226 | 0.103 | GAEP01002006 |
| 63 | 3FTx-15 | 1 | 625 | 0.202 | 0.092 | GAEP01001956 |
| 64 | HYAL-1 | 1 | 1,448 | 0.195 | 0.089 | GAEP01001981 |
| 65 | VEGF-3 | 1 | 1,422 | 0.171 | 0.078 | GAEP01002066 |
| 66 | 3FTx-8 | 1 | 707 | 0.131 | 0.060 | GAEP01001975 |
| 67 | PDE-1 | 1 | 3,003 | 0.114 | 0.052 | GAEP01002007 |
| 68 | KUN-8 | 1 | 571 | 0.072 | 0.033 | GAEP01001990 |
| 69 | KUN-5 | 1 | 400 | 0.063 | 0.029 | GAEP01001987 |
| 70 | PLA2-10 | 1 | 1,120 | 0.055 | 0.025 | GAEP01002008 |
| 71 | 3FTx-5 | 2 | 1,680 | 0.051 | 0.023 | a: GAEP01001971 |
| | | | | | | b: GAEP01001972 |
| 72 | KUN-6 | 1 | 304 | 0.026 | 0.012 | GAEP01001988 |
| 73 | KUN-4 | 1 | 856 | 0.024 | 0.011 | GAEP01001986 |
| 74 | CREGF-1 | 1 | 1,573 | 0.014 | 0.007 | GAEP01001977 |
| 75 | CTL-2 | 1 | 1,020 | 0.009 | 0.004 | GAEP01001980 |
Figure 2The venom-gland transcriptome of was dominated by phospholipases A and three-finger toxins. Toxin gene expression was dominated by phospholipases A2 (PLA2s) and three-finger toxins (3FTxs). Full-length transcripts accounted for 57.1% of the total reads; toxin sequences accounted for 45.8% of the total reads. PLA2s and 3FTxs represent both the most abundant and most diverse toxin classes identified; 31 PLA2 clusters accounted for 64.9% of the toxin reads, and 15 3FTx clusters accounted for 21.1% of the toxin reads. Toxin sequences accounted for 10.4% more of the total reads in M. fulvius than in C. adamanteus, while nontoxins in C. adamanteus accounted for more than twice the total read percentage than in M. fulvius. The venom of M. fulvius was dominated by small neurotoxic components while the venom of C. adamanteus was dominated by larger hemorrhage-inducing proteins, suggesting that the transcriptional effort expended on toxins versus nontoxins may differ between venoms dominated by high-molecular weight components and venoms dominated by smaller proteins, with small-component venoms expressing toxins at much higher levels relative to nontoxin production.
Low abundance toxin classes
| CTL | 2 | 3 | 0.80 | 0.365 | Disruption of hemostasis [ |
| CREGF | 1 | 1 | 0.01 | 0.007 | Substrate recognition and specificity [ |
| HYAL | 1 | 1 | 0.20 | 0.089 | Degradation of extracellular matrix and |
| | | | | | connective tissue; spreading factor [ |
| LAAO | 1 | 3 | 0.88 | 0.403 | Edema, platelet aggregation, and apoptosis |
| | | | | | due to the liberation of peroxides [ |
| NP | 1 | 1 | 0.70 | 0.321 | Hypotension [ |
| NGF | 1 | 2 | 0.58 | 0.264 | Induction of apoptosis in neuronal cells [ |
| NUC | 1 | 1 | 0.23 | 0.103 | Liberation of toxic nucleosides [ |
| PDE | 1 | 1 | 0.11 | 0.052 | Hydrolysis of phosphodiester bonds; hypotension [ |
| PLB | 1 | 1 | 0.34 | 0.154 | Unknown; potentially hemolytic and/or cytotoxic [ |
| VEGF | 3 | 3 | 1.05 | 0.479 | Hypotension and augmentation of vascular permeability [ |
Abbreviations. CTL C-type lectin, CREGF Cysteine-rich with EGF-like domain, HYAL hyaluronidase, LAAO L amino-acid oxidase, NP natriuretic peptide, NGF nerve growth factor, NUC nucleotidase, PDE phosphodiesterase, PLB phospholipase B, VEGF vascular endothelial growth factor.
Putative SNPs in 69 of the 1,950 nontoxin and nine of the 75 toxin sequences
| 40S ribosomal protein S14 | Nontoxin | 762 | 292 | 52.0 | D | |
| 40S ribosomal protein S18 | Nontoxin | 284 | 424 | 47.2 | N | |
| 40S ribosomal protein S23 | Nontoxin | 510 | 97 | 51.2 | K | |
| 6-phosphogluconate dehydrogenase | Nontoxin | 33 | 624 | 54.5 | V | |
| 60S ribosomal protein L29 | Nontoxin | 411 | 45 | 51.3 | K | |
| 60S ribosomal protein L32 | Nontoxin | 525 | 332 | 47.8 | K | |
| Actin-related protein 2/3 complex subunit 3 | Nontoxin | 30 | 255 | 50.0 | R | |
| Alanine aminotransferase 2-like protein | Nontoxin | 23 | 241 | 43.5 | T | |
| Alpha globin | Nontoxin | 26 | 435 | 50.0 | F →L | |
| Aminopeptidase N | Nontoxin | 32 | 2,592 | 46.9 | R →C | |
| Annexin A2 | Nontoxin | 66 | 302 | 42.4 | T →A | |
| Annexin A4 | Nontoxin | 286 | 248 | 44.4 | A | |
| Annexin A5 | Nontoxin | 99 | 236 | 50.5 | S | |
| ATP synthase H + transporting mitochondrial F0 | Nontoxin | 109 | 178 | 45.9 | L | |
| Bifunctional heparan sulfate N-deacetylase/ | Nontoxin | 20 | 2,445 | 45.0 | M →T | |
| N-sulfotransferase 2-like protein | | | | | | |
| C4orf34 | Nontoxin | 1,021 | 175 | 48.5 | A | |
| Caprin-1 | Nontoxin | 46 | 1,327 | 45.7 | S →P | |
| Cell cycle progression protein 1 | Nontoxin | 22 | 708 | 45.5 | G | |
| | | 52 | 2,286 | 42.3 | K →E | |
| Cellular nucleic acid-binding protein | Nontoxin | 83 | 156 | 56.6 | T | |
| Chloride intracellular channel protein 1 | Nontoxin | 112 | 447 | 58.0 | D | |
| Clathrin interactor 1 | Nontoxin | 36 | 1,731 | 50.0 | P | |
| Cyclic AMP-responsive element-binding protein 3 | Nontoxin | 25 | 482 | 44.0 | D | |
| Cytochrome c oxidase subunit 4 | Nontoxin | 76 | 227 | 47.4 | E →A | |
| Dynactin subunit 6 1 | Nontoxin | 35 | 424 | 51.4 | I | |
| Ectonucleoside triphosphate diphosphohydrolase 7 | Nontoxin | 27 | 901 | 48.1 | K →E | |
| Endoplasmic reticulum oxidoreductin 1-Lbeta | Nontoxin | 260 | 1,247 | 54.6 | G | |
| EPS8 | Nontoxin | 49 | 2,112 | 49.0 | Q →H | |
| Eukaryotic initiation factor 4A-1 | Nontoxin | 29 | 409 | 44.8 | H | |
| | | 24 | 496 | 41.7 | R | |
| | | 32 | 559 | 53.1 | D | |
| Eukaryotic translation elongation factor 1 gamma | Nontoxin | 313 | 908 | 50.5 | I | |
| Eukaryotic translation initiation | Nontoxin | 43 | 73 | 41.9 | I | |
| | | 40 | 1,067 | 47.5 | H | |
| Eukaryotic translation initiation factor 2 subunit | Nontoxin | 37 | 1,172 | 51.4 | L | |
| Eukaryotic translation initiation factor 3 | Nontoxin | 42 | 3,200 | 52.4 | G | |
| Eukaryotic translation initiation factor 5A-1 | Nontoxin | 71 | 77 | 45.1 | D | |
| | | 75 | 86 | 45.3 | T | |
| | | 98 | 143 | 48.0 | N | |
| | | 139 | 384 | 56.1 | R | |
| | | 108 | 447 | 52.8 | S | |
| | | 72 | 486 | 54.2 | T | |
| Fructose-1,6-bisphosphatase 1 | Nontoxin | 54 | 1,078 | 44.4 | R | |
| GABA | Nontoxin | 31 | 144 | 45.2 | R | |
| | | 42 | 159 | 54.8 | D | |
| Guanine nucleotide-binding protein | Nontoxin | 30 | 569 | 46.7 | A →T | |
| Guanine nucleotide-binding protein subunit beta-2 | Nontoxin | 541 | 149 | 51.2 | T | |
| Hydroxyacylglutathione hydrolase | Nontoxin | 21 | 190 | 52.4 | W →R | |
| | | 23 | 709 | 47.8 | S →P | |
| Integrin-linked protein kinase | Nontoxin | 29 | 1,205 | 55.2 | A | |
| Interferon-related developmental regulator 2 | Nontoxin | 22 | 709 | 45.5 | A →T | |
| | | 23 | 709 | 47.8 | S →P | |
| Integrin-linked protein kinase | Nontoxin | 29 | 1,205 | 55.2 | A | |
| Interferon-related developmental regulator 2 | Nontoxin | 22 | 709 | 45.5 | A →T | |
| LAG1 longevity assurance protein 2 | Nontoxin | 41 | 896 | 53.7 | T | |
| LAMTOR2 | Nontoxin | 81 | 468 | 53.1 | L | |
| LIM domain and actin-binding protein | Nontoxin | 28 | 1,516 | 50.0 | V →A | |
| Lysine-specific histone demethylase 1B | Nontoxin | 70 | 122 | 44.3 | D →G | |
| Lysosomal cobalamin transporter | Nontoxin | 27 | 184 | 48.1 | A | |
| Malate dehydrogenase | Nontoxin | 68 | 1,059 | 57.4 | L | |
| Mannose-1-phosphate guanyltransferase beta | Nontoxin | 32 | 698 | 53.1 | P →S | |
| Microspherule protein 1 | Nontoxin | 24 | 665 | 50.0 | V →A | |
| Minor histocompatibility antigen H13 1 | Nontoxin | 452 | 1,164 | 53.5 | P →L | |
| MTP4 | Nontoxin | 1,664 | 503 | 59.3 | D | |
| | | 1,480 | 1,621 | 49.8 | P →S | |
| NADH dehydrogenase | Nontoxin | 40 | 213 | 40.0 | I →V | |
| NADPH-cytochrome P450 oxidoreductase | Nontoxin | 28 | 286 | 53.6 | T | |
| Nuclease-sensitive element-binding protein 1 | Nontoxin | 91 | 675 | 56.0 | R | |
| Polyubiquitin-C isoform 2 | Nontoxin | 892 | 350 | 57.4 | G | |
| | | 637 | 560 | 52.3 | F | |
| | | 593 | 635 | 51.8 | K | |
| | | 774 | 917 | 52.8 | A | |
| | | 697 | 950 | 49.6 | S | |
| Proteasome | Nontoxin | 83 | 430 | 59.0 | F | |
| Proteasome subunit alpha type-6 | Nontoxin | 48 | 139 | 52.1 | H | |
| Protein disulfide-isomerase A3 | Nontoxin | 146 | 196 | 50.0 | C | |
| Sarcolemmal membrane-associated protein-3 | Nontoxin | 21 | 1,534 | 42.9 | Q | |
| SEC31 | Nontoxin | 110 | 2,866 | 46.4 | P | |
| Serine/threonine-protein phosphatase | Nontoxin | 22 | 1,144 | 40.9 | T →S | |
| | | 22 | 1,337 | 45.5 | S | |
| Sialin | Nontoxin | 23 | 321 | 43.5 | P | |
| Sodium/glucose cotransporter 4 | Nontoxin | 26 | 579 | 57.7 | S →C | |
| | | 26 | 580 | 57.7 | S →T | |
| Stress-induced-phosphoprotein 1 | Nontoxin | 22 | 455 | 50.0 | L | |
| | | 21 | 716 | 52.4 | K | |
| Transmembrane emp24 domain-containing | Nontoxin | 347 | 595 | 46.1 | Y | |
| Tubulin beta-5 chain | Nontoxin | 27 | 1,340 | 44.4 | A | |
| V-type proton ATPase catalytic subunit A | Nontoxin | 63 | 1,344 | 55.6 | I | |
| Y box binding protein 1 | Nontoxin | 91 | 811 | 59.3 | R | |
| YTH domain family protein 1 | Nontoxin | 25 | 1,347 | 44.0 | P | |
| C-type lectin 1a | Toxin | 7,320 | 360 | 55.1 | G | |
| C-type lectin 2 | Toxin | 130 | 598 | 48.5 | N | |
| Cysteine-rich with EGF-like domain 1 | Toxin | 48 | 257 | 50.0 | K | |
| | | 82 | 949 | 45.1 | T | |
| Kunitz inhibitor 1a | Toxin | 12,402 | 280 | 42.5 | G →R | |
| L-amino acid oxidase 1a | Toxin | 1,850 | 769 | 55.0 | Y | |
| | | 3,094 | 1,158 | 41.2 | H →Q | |
| Long chain neurotoxin 3 | Toxin | 7,081 | 402 | 40.1 | V →I | |
| Phospholipase A2 31 | Toxin | 20 | 62 | 40.0 | S | |
| Phospholipase A2 9 | Toxin | 68 | 44 | 50.0 | N →I | |
| Venom nerve growth factor 1a | Toxin | 3,689 | 316 | 49.3 | P →S |
Figure 3The expression of three-finger toxins was extremely biased in. Expression of three-finger toxin (3FTx) sequences was dominated by several multitranscript cluster members, suggesting a significant role for recent gene duplication within the gene family. A homologous toxin sequence from the mangrove snake (Boiga dendrophila) was used as an outgroup to root the phylogeny. Bayesian posterior probability values exceeding 50% are shown. Adjacent bars indicate expression levels relative to the most highly expressed member of the class, with a completely filled bar indicating the most highly expressed transcript of the class. (A) A maximum-likelihood phylogeny of M. fulvius 3FTx clusters under the HKY+G model. 3FTx expression levels were dominated by a handful of sequences, all representatives of multitranscript clusters (as indicated by the letter following the cluster number), suggesting a relationship between gene duplication and expression. (B) A maximum- likelihood phylogeny of M. fulvius transcripts identified in this study as well as orthologous 3FTx transcripts from M. corallinus and M. altirostris under the HKY+G model. Tips are color-coded by species. The subclade containing nine M. altirostris transcripts is sister to a sub-clade containing a single M. altirostris sequence and 3FTx-13 from M. fulvius. 3FTx-13 is expressed at a relatively low level, suggesting that the divergence of toxins occurs following speciation, at least for this one 3FTx paralog.
Figure 4The expression of phospholipases A was uniform across transcripts in. The phospholipase A2 (PLA2) gene family was characterized by an even distribution of expression levels. A homologous toxin sequence from the eastern diamondback rattlesnake (Crotalus adamanteus) was used as an outgroup to root the phylogeny. The root branch was shortened for visual clarity and is indicated by the dashed line. Bayesian posterior probability values exceeding 50% are shown. Adjacent bars indicate expression levels relative to the most highly expressed member of the class, with a completely filled bar indicating the most highly expressed transcript of the class. (A) A maximum-likelihood phylogeny of M. fulvius PLA2 clusters under the SYM+G model. PLA2 expression levels were much more evenly distributed throughout the class in comparison to 3FTx transcript expression levels (Figure 4). (B) A maximum-likelihood phylogeny of M. fulvius transcripts identified in this study as well as orthologous PLA2 transcripts from M. corallinus and M. altirostris under the SYM+G model. Tips are color-coded by species. The sub-clade containing the M. altirostris transcripts again suggests divergence among toxins may occur following speciation events.
Summary of codeml results
| 3FTx | 26 | 1,600.40 | 1,576.50 | 1.48 | 47.8 | 4.17 ×10−11* | ||
| | F81+G | | | | | | ||
| KUN | 9 | 965.08 | 962.16 | 0.58 | 5.84 | 5.39 ×10−2 | ||
| | GTR+G | | | | | | ||
| LCN | 9 | 315.85 | 305.84 | 999.00 | 20.02 | 4.49 ×10−5* | ||
| | JC+I | | | | | | ||
| PLA2 | 52 | 4,761.33 | 4,359.71 | 3.32 | 443.24 | 0.00* | ||
| SYM+G |
dN/dS ratios are represented by ω; λ represents our test statistic which is negative twice the difference in log likelihoods compared across models to a χ2 distribution with two degrees of freedom; and p corresponds to the proportion of codon sites falling into one of three rate classes which are purifying selection, neutral selection, and positive selection, respectively. The model selected by MrModelTest2.3 [50] for the estimation of the maximum-likelihood phylogeny is given and n corresponds to the number of sequences used in the analysis. Significant p-values are indicated by an asterisk.